Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial

AIMS: Heart failure (HF) is a multifactorial disease. Current treatments target only a fraction of the putative pathophysiological pathways. In patients with HF, reduced cardiac output and congestion cause increased gut wall permeability. It has been suggested that leakage of microbial products is d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESC Heart Fail
Main Authors: Mayerhofer, Cristiane C.K., Awoyemi, Ayodeji O., Moscavitch, Samuel D., Lappegård, Knut Tore, Hov, Johannes R., Aukrust, Pål, Hovland, Anders, Lorenzo, Andrea, Halvorsen, Sigrun, Seljeflot, Ingebjørg, Gullestad, Lars, Trøseid, Marius, Broch, Kaspar
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Study Designs
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6165929/
https://ncbi.nlm.nih.gov/pubmed/30088346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12332
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados